These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 37962780)
21. Factors influencing pharmacists' clinical decision making in pharmacy practice. Mertens JF; Koster ES; Deneer VHM; Bouvy ML; van Gelder T Res Social Adm Pharm; 2023 Sep; 19(9):1267-1277. PubMed ID: 37236847 [TBL] [Abstract][Full Text] [Related]
22. Audit of community pharmacists' prescribing interventions: Quality assessment of a newly reimbursed service. MacKeigan LD; Dolovich L; Petrovic B; MacCallum L; Bojarski EA; Pojskic N J Am Pharm Assoc (2003); 2018; 58(6):622-629. PubMed ID: 30190200 [TBL] [Abstract][Full Text] [Related]
23. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges. Hattingh HL; Kelly F; Fowler J; Wheeler AJ Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302 [TBL] [Abstract][Full Text] [Related]
24. What predicts pharmacists' engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy. Nielsen S; Sanfilippo P; Picco L; Bruno R; Kowalski M; Wood P; Larney S Int J Clin Pharm; 2021 Apr; 43(2):420-429. PubMed ID: 32533428 [TBL] [Abstract][Full Text] [Related]
25. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available. Shepherd MD J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of an enhanced service for medication review with follow up in Swiss community pharmacies: Pre-post study protocol. Amador-Fernández N; Escaith M; Simi E; Quintana-Bárcena P; Berger J PLoS One; 2023; 18(10):e0292037. PubMed ID: 37847695 [TBL] [Abstract][Full Text] [Related]
27. Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies. Desmaele S; De Wulf I; Dupont AG; Steurbaut S Int J Clin Pharm; 2015 Aug; 37(4):656-68. PubMed ID: 25822042 [TBL] [Abstract][Full Text] [Related]
28. Impact of a blended learning program on community pharmacists' barriers, knowledge, and counseling practice with regard to preconception, pregnancy and lactation. Ceulemans M; Liekens S; Van Calsteren K; Allegaert K; Foulon V Res Social Adm Pharm; 2021 Jul; 17(7):1242-1249. PubMed ID: 32952090 [TBL] [Abstract][Full Text] [Related]
29. Exploring the early phase of implementation of a vaccine-based clinical decision support system in the community pharmacy. Frederick KD; Gatwood JD; Atchley DR; Rein LJ; Ali SG; Brookhart AL; Crain J; Hagemann TM; Ramachandran S; Chiu CY; Hohmeier KC J Am Pharm Assoc (2003); 2020; 60(6):e292-e300. PubMed ID: 32389555 [TBL] [Abstract][Full Text] [Related]
30. Hospital pharmacists' ethical exposure and decision-making. So B; Tuche M; King MA; Hope DL; La Caze A; Hattingh HL Res Social Adm Pharm; 2021 Feb; 17(2):372-380. PubMed ID: 32284299 [TBL] [Abstract][Full Text] [Related]
31. Management of drug-interaction alerts in community pharmacies. Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663 [TBL] [Abstract][Full Text] [Related]
32. Drug-related problems detected in Australian Community Pharmacies: The PROMISe Trial. Williams M; Peterson GM; Tenni PC; Bindoff IK; Curtain C; Hughes J; Bereznicki LR; Jackson SL; Kong DC; Hughes JD Ann Pharmacother; 2011 Sep; 45(9):1067-76. PubMed ID: 21878658 [TBL] [Abstract][Full Text] [Related]
33. The clinical pharmacist's role in enhancing the relevance of a clinical decision support system. Cuvelier E; Robert L; Musy E; Rousselière C; Marcilly R; Gautier S; Odou P; Beuscart JB; Décaudin B Int J Med Inform; 2021 Nov; 155():104568. PubMed ID: 34537687 [TBL] [Abstract][Full Text] [Related]
34. Anticoagulation management services in community pharmacy: Feasibility of implementing a quality improvement programme through a practice-based research network. Chartrand M; Lalonde L; Cantin A; Lahaie A; Odobasic B; Tremblay MP; Wazzan D; Gagnon MM; Martin É; Dorais M; Berbiche D; Guénette L J Clin Pharm Ther; 2018 Dec; 43(6):877-887. PubMed ID: 30019341 [TBL] [Abstract][Full Text] [Related]
35. Community pharmacists' experience relying on select implementation strategies in the delivery of comprehensive medication management. Levitt JM; Pestka DL; Blanchard CM; Sorge LA; Sorensen TD J Am Pharm Assoc (2003); 2022; 62(5):1648-1653.e1. PubMed ID: 35550731 [TBL] [Abstract][Full Text] [Related]
36. "It is the future. Clinical pharmaceutical care simply has to be a matter of course." - Community pharmacy clinical service providers' and service developers' views on complex implementation factors. Weidmann AE; Hoppel M; Deibl S Res Social Adm Pharm; 2022 Dec; 18(12):4112-4123. PubMed ID: 35987672 [TBL] [Abstract][Full Text] [Related]
37. Implementation of a medication therapy management collaborative within a pediatric health system. Sneed G; Kappeler K; Gilmore T; Kuhn C J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801 [TBL] [Abstract][Full Text] [Related]
38. Review of computerized clinical decision support in community pharmacy. Curtain C; Peterson GM J Clin Pharm Ther; 2014 Aug; 39(4):343-8. PubMed ID: 24806361 [TBL] [Abstract][Full Text] [Related]
39. A qualitative exploration of mental health services provided in community pharmacies. Crespo-Gonzalez C; Dineen-Griffin S; Rae J; Hill RA PLoS One; 2022; 17(5):e0268259. PubMed ID: 35551556 [TBL] [Abstract][Full Text] [Related]
40. Care coordination and follow-up practices in the community pharmacy setting: A mixed methods study. Renfro CP; Robinson JM; Turner K; Gaskins T; Ferreri SP J Am Pharm Assoc (2003); 2020; 60(4):631-638.e2. PubMed ID: 31919008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]